BPH Clinical Trials 2024

BPH Clinical Trials 2024

BPH research studies recruiting patients in 2024 need your help. Receive premium care & cutting edge treatments by enrolling in benign prostatic hyperplasia clinical trials today.

Trials for Enlarged Prostate Patients

Trials for Lower Urinary Tract Symptoms Patients

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to bph

What are the top hospitals conducting bph research?

When it comes to clinical trials focused on finding new treatments for benign prostatic hyperplasia (BPH), several hospitals across different locations are making significant contributions. In Cleveland, the University Hospitals Cleveland Medical Center leads the way with 1 active BPH trial and a total of 1 trial conducted since recording their first one in 2023. Another facility within the same healthcare system, UH Brainard Medical Building in Lyndhurst, is also actively involved in BPH research with similar numbers of ongoing and completed trials. Similarly, at UH Regional Hospitals - Richmond Campus in Richmond Heights, researchers are conducting an active BPH trial while having completed one previously recorded trial.

Moving outside Ohio, Thunder Bay Regional Health Sciences Centre located in Thunder Bay has made substantial progress as well. This Canadian hospital has an ongoing BPH trial and has successfully conducted one prior study since their initial recorded trial back in 2022. Lastly, the Urology Specialist Group based in Hialeah contributes to advancing our understanding of BPH through its involvement in current and past trials focusing on this condition.

Although these specific hospitals may have limited data available for bph clinical trials at present, they demonstrate a commitment to researching better solutions for patients dealing with this common urological issue characterized by enlargement of the prostate gland that can cause urinary symptoms such as frequent urination or weak urine flow. It's important to recognize that medical advancements take time and require meticulous investigation before reaching conclusive results; nonetheless, the dedication shown by these institutions signifies promising steps towards improving treatment options for those affected by BPH.

Which are the best cities for bph clinical trials?

When it comes to bph clinical trials, several cities show promise in advancing research and treatment options. Thunder Bay, Ontario stands out with 2 active trials examining therapies like the Thulium Fibre Laser and Top-Down HoLEP. Cleveland, Ohio along with its neighboring towns of Lyndhurst and Richmond Heights also contribute to the effort with 1 active trial each focusing on Intravesical Botox injection. Additionally, Hialeah, Florida offers a study on SoracteLite(TM) TPLA for BPH. These cities provide individuals with opportunities to participate in cutting-edge clinical trials that may lead to improved management strategies for benign prostatic hyperplasia (BPH).

Which are the top treatments for bph being explored in clinical trials?

Exciting developments in the field of BPH treatment are emerging from ongoing clinical trials. Prostate Artery Embolization, a procedure that involves blocking blood flow to the prostate to reduce its size, is currently being explored in two active trials and has accumulated five all-time BPH trials since 2014. Another promising option is Intravesical Botox injection, with one active trial underway. Thulium Fibre Laser also shows potential with one active trial investigating its efficacy for BPH treatment. Lastly, SoracteLite(TM) TPLA for BPH has shown promise in one active trial since its introduction in 2020. These innovative treatments offer hope for patients suffering from this common condition and may provide effective alternatives to traditional approaches such as medication or surgery.

What are the most recent clinical trials for bph?

Recent clinical trials have offered new insights and potential treatment options for individuals with benign prostatic hyperplasia (BPH). One noteworthy trial is evaluating a treatment group specifically designed to address the symptoms associated with BPH. Another study focuses on SoracteLite(TM) TPLA, a novel approach that shows promise in managing BPH. These trials highlight the ongoing efforts to improve patient outcomes and quality of life in those affected by this condition.

What bph clinical trials were recently completed?

Two recent clinical trials have explored potential treatments for benign prostatic hyperplasia (BPH). In September 2019, Urovant Sciences GmbH completed a trial investigating the efficacy of Vibegron. Another trial sponsored by the same company concluded in March 2019 and also focused on evaluating Vibegron's effectiveness for BPH. These studies contribute to our understanding of therapeutic options for individuals experiencing this condition and may pave the way for improved management strategies in the future.